Last updated: 5 March 2024 at 5:06pm EST

Dr. Jose-Carlos Gutierrez-Ramos Ph.D. Net Worth




The estimated Net Worth of Jose Carlos Gutierrez Ramos is at least $2.45 Million dollars as of 21 August 2023. Dr Ramos owns over 590 units of Danaher stock worth over $1,887,269 and over the last 9 years he sold DHR stock worth over $562,533.

Dr D DHR stock SEC Form 4 insiders trading

Dr has made over 6 trades of the Danaher stock since 2018, according to the Form 4 filled with the SEC. Most recently he sold 590 units of DHR stock worth $147,819 on 21 August 2023.

The largest trade he's ever made was selling 10,090 units of Danaher stock on 21 January 2020 worth over $293,619. On average, Dr trades about 1,009 units every 61 days since 2016. As of 21 August 2023 he still owns at least 6,939 units of Danaher stock.

You can see the complete history of Dr Ramos stock trades at the bottom of the page.





Dr. Jose-Carlos Gutierrez-Ramos Ph.D. biography

Dr. Jose-Carlos Gutierrez-Ramos Ph.D. is the Sr. VP & Chief Science Officer at Danaher.



How old is Dr D?

Dr D is 57, he's been the Sr. VP & Chief Science Officer of Danaher since . There are 9 older and 15 younger executives at Danaher. The oldest executive at Danaher Corp. is John Schwieters, 80, who is the Independent Director.

What's Dr D's mailing address?

Jose's mailing address filed with the SEC is 2200 PENNSYLVANIA AVENUE NW, SUITE 800W, WASHINGTON, DC, 20037.

Insiders trading at Danaher

Over the last 20 years, insiders at Danaher have traded over $2,183,160,204 worth of Danaher stock and bought 226,618 units worth $34,863,916 . The most active insiders traders include Steven M Rales, Mitchell P Rales und Robert J Hugin. On average, Danaher executives and independent directors trade stock every 14 days with the average trade being worth of $25,840,276. The most recent stock trade was executed by Georgeann Couchara on 26 August 2024, trading 952 units of DHR stock currently worth $255,488.



What does Danaher do?

Danaher Corporation is an American globally diversified conglomerate founded by brothers Stephen and Mitchell Rales in 1984. Headquartered in Washington, D.C., the company designs, manufactures, and markets medical, industrial, and commercial products and services.



Complete history of Dr Ramos stock trades at Momenta Pharmaceuticals, Danaher, Synlogic Inc, Evelo Biosciences Inc und Bicycle Therapeutics plc

Insider
Trans.
Transaktion
Gesamtpreis
Jose Carlos Gutierrez Ramos
SVP und Chief Science Officer
Verkauf $147,819
21 Aug 2023
Jose Carlos Gutierrez Ramos
SVP und Chief Science Officer
Verkauf $121,095
1 May 2023
Jose Carlos Gutierrez Ramos
Direktor
Optionausübung $85,900
19 Aug 2020
Jose Carlos Gutierrez Ramos
Direktor
Verkauf $293,619
21 Jan 2020
Jose Carlos Gutierrez Ramos
Direktor
Optionausübung $55,060
19 Jun 2019
Jose Carlos Gutierrez Ramos
Direktor
Optionausübung $127,868
20 Jun 2018


Danaher executives and stock owners

Danaher executives and other stock owners filed with the SEC include: